Colorectal Cancer

>

Latest News

Nivolumab Plus Ipilimumab May Ease Symptom Burden in MSI-H/dMMR Metastatic Colorectal Cancer
Nivolumab Plus Ipilimumab May Ease Symptom Burden in MSI-H/dMMR Metastatic Colorectal Cancer

July 18th 2024

Nivolumab plus ipilimumab improved health-related quality of life and reduced symptom burden in patients with microsatellite instability–high/mismatch repair–deficient mCRC.

Celecoxib Plus Adjuvant Chemo Provides Survival Benefit for PIK3CA-Mutated Stage III Colon Cancer
Celecoxib Plus Adjuvant Chemo Provides Survival Benefit for PIK3CA-Mutated Stage III Colon Cancer

July 12th 2024

Oncology Drugs Approved by the FDA in June 2024
Oncology Drugs Approved by the FDA in June 2024

July 1st 2024

Opinion: The Western Diet May Contribute to Young-Onset Colorectal Cancer
Opinion: The Western Diet May Contribute to Young-Onset Colorectal Cancer

June 24th 2024

FDA Approves Adagrasib for KRAS G12C-Mutated Metastatic Colorectal Cancer
FDA Approves Adagrasib for KRAS G12C-Mutated Metastatic Colorectal Cancer

June 21st 2024

© 2024 MJH Life Sciences

All rights reserved.